+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

From
From
Blarcamesine - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine - Global Strategic Business Report

  • Report
  • November 2025
  • 370 Pages
  • Global
From
Learning Disabilities Treatment - Global Strategic Business Report - Product Thumbnail Image

Learning Disabilities Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 388 Pages
  • Global
From
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 276 Pages
  • Global
From
Asperger Syndrome - Global Strategic Business Report - Product Thumbnail Image

Asperger Syndrome - Global Strategic Business Report

  • Report
  • November 2025
  • 204 Pages
  • Global
From
Delirium - Global Strategic Business Report - Product Thumbnail Image

Delirium - Global Strategic Business Report

  • Report
  • November 2025
  • 281 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • November 2025
  • 367 Pages
  • Global
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • November 2025
  • 372 Pages
  • Global
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Multiple Sclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 235 Pages
  • Global
From
Parkinson's Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 93 Pages
  • Global
From
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 276 Pages
  • Global
From
Dementia Treatment - Global Strategic Business Report - Product Thumbnail Image

Dementia Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 204 Pages
  • Global
From
Multiple Sclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 268 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 376 Pages
  • Global
From
Frontotemporal Dementia - Global Strategic Business Report - Product Thumbnail Image

Frontotemporal Dementia - Global Strategic Business Report

  • Report
  • November 2025
  • 381 Pages
  • Global
From
Loading Indicator